A new study demonstrates that a first-of-its-kind platform using artificial intelligence (AI) could help clinicians and patients assess whether and how much an individual patient may benefit from a ...
Immunic Therapeutics says it's "on track" in its MS clinical trials of vidofludimus calcium, with CALLIPER top-line data ...
GlobalData on MSN12h
Contineum concludes enrolment in Phase II multiple sclerosis therapy trialContineum Therapeutics has concluded the targeted enrolment of 168 subjects in its Phase II trial of M1 receptor antagonist ...
A study led by Winship Cancer Institute of Emory University and Abramson Cancer Center of the University of Pennsylvania ...
Veeva share price has recently been battling concerns that Salesforce will become a more aggressive competitor and take ...
Both parties will also expand research and development efforts. National Taiwan University Hospital (NTUH) and AbbVie ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback